Inclusion Criteria:

- Male or non-pregnant female between 18 and 60 years of age

- Able to give verbal and written informed consent

- For women of childbearing potential (WOCBP) or in men whose partners may become
pregnant, willingness to use an acceptable method of contraception to prevent
pregnancy for the duration of the study (while receiving study medication and for one
month following the last dose of study medication). Acceptable forms of contraception
are listed in the protocol.

- Must have a negative urine pregnancy test (for WOCBP)

Exclusion Criteria:

- Subjects taking any of the following systemic or topical therapies within 4 weeks of
enrollment: corticosteroids, immunosuppressants, and/or any other medications that
may affect the outcome of the study

- Known sensitivity to bandage or adhesive tape.

- Subjects who have active localized or systemic medical conditions that, in the
opinion of the investigator, would preclude or make unsafe their participation in the
study

- Subjects with any underlying concomitant diagnosis that may influence immune
reactions (e.g. eczema, psoriasis, lupus)

- Subjects who are nursing mothers, pregnant, or planning to become pregnant at anytime
during the course of the study or within 30 days of study completion

- Subjects who are unable to comply with study procedures, communicate effectively,
cooperate with the investigator, or are unable to understand the study

- Subjects who have been treated with another investigational device or drug within 30
days of enrollment

- HIV positive as determined by self-reported history and/or a HIV POCT at screening

- History, physical, social or lab findings suggestive of any medical or psychological
condition that would, in the opinion of the PI, make the candidate ineligible for the
study